Pedro E Cahn

8PUBLICATIONS
55CO-AUTHORS
Gene and molecular therapyTransgender studiesSensory processes, perception and performancePharmacogenomicsVirology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 29, 2026
Antiviral Effect, Safety, and Tolerability of Oral VH4011499 (VH-499), a New HIV-1 Capsid Inhibitor: Proof-of-Concept Trial.

|Jul 20, 2026
Sociodemographic and Behavioral Characteristics and HIV and Syphilis Prevalence Among Partners of Transgender Women in Buenos Aires, Argentina.

|Apr 17, 2026
Viral variant but not host factors associate with SARS-CoV-2 viral kinetics.

|Sep 02, 2025
VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Antidrug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study Results.

Peter A Leone, Alejandro Ferro, Charlotte-Paige Rolle

|Aug 28, 2025
Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.

Maria Ines Figueroa, Carlos Brites, Diego Cecchini

|Jun 11, 2025
Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH).

Pedro Cahn, Luis Barreto, Maria Ines Figueroa

Pageof 2

Frequent Collaborators

1 joint publications

Ezequiel Lacunza

1 joint publications

Romina Canzoneri

1 joint publications

Julián Naipauer

1 joint publications

Omar Sued